The ARREST-TB Project
The ARREST-TB project aims to develop a suite of technologies to rapidly, accurately and economically detect, report and monitor TB and MDR TB, and monitor response to anti-TB treatments.
Tuberculosis (TB) is the most lethal infectious disease, claiming 1.6 million lives in 2017. Drug-resistant TB cases continue to rise and the World Health Organisation estimates that only 25% of all cases are actually identified.
TB is curable if diagnosed on time and it is estimated that treatment saved the lives of 54million people between 2000 and 2017.
However, several high TB burden countries have poor access to appropriate diagnosis, as most of the current ‘gold standard’ diagnostic tools are expensive and ill adapted to resource-limited settings.
New affordable diagnostic tools are urgently required to improve detection of TB, especially in difficult to diagnose groups, for drug-resistant cases and in settings where lab infrastructure is limited.
Do you have any questions about The ARREST-TB project?
Financial Support
This project receives financial support from the European Commission’s Horizon 2020 research and innovation programme under grant agreement No 825931.
Our Latest News
-
Tuberculosis Tag at Explorathon
On the 28th of October, members of the ARREST TB project used a game of Tuberculosis Tag developed for the Explorathon events at Heriot-Watt by Dr Helen Bridle to educate science enthusiasts of all ages on the threat of multi-drug
-
ARREST TB at Explorathon
ARREST TB members, led by Dr Helen Bridle will be hosting an event for Explorathon 2019 at the Lyell Centre on the Heriot-Watt University campus on the 28th of September 2019. The event is free but attendees are encouraged
-
ARREST TB consortium meeting in Edinburgh
Edinburgh played host to the latest meeting of the ARREST TB project. Attendees from research institutes, universities, and companies across Europe, Russia, and India presented their work over two days, with significant progress demonstrated by all. The next meeting is